XML 105 R89.htm IDEA: XBRL DOCUMENT v3.25.0.1
Fair Value Of Financial Instruments (Narrative) (Details) - USD ($)
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Fair value, transfers between three levels $ 0 $ 0
Cash and cash equivalents $ 570,100,000 1,040,000,000.00
Estimated selling costs, percentage reduction 7.00%  
Estimated selling costs 10.00%  
Time deposits $ 0 0
Collateral dependent loans 10,900,000 11,800,000
Specific reserves and other write downs on impaired loans $ 4,300,000 2,900,000
Fair Value, Measurements, Nonrecurring [Member]    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Estimated selling costs, percentage reduction 7.00%  
Estimated selling costs 10.00%  
Collateral dependent loans [1] $ 6,587,000 $ 8,944,000
[1]

Fair Value Measurements at Reporting Date Using

Quoted prices in active

Significant other

Significant

markets for identical

observable

unobservable

Fair value

assets

inputs

inputs(1)

Description

December 31, 2023

(Level 1)

(Level 2)

(Level 3)

Collateral dependent loans with specific reserves(1)

$

8,944 

$

—

$

—

$

8,944 

OREO

16,949 

—

—

16,949 

$

25,893 

$

—

$

—

$

25,893 

(1) The method of valuation approach for the loans evaluated for an allowance for credit losses on an individual loan basis and also for OREO was the market approach based upon appraisals of the underlying collateral by external appraisers, reduced by 7% to 10% for estimated selling costs.